14

HOB Biotech Group Corp LtdSHG 1438908D Stock Report

Last reporting period 30 Sep, 2023

Updated —

Last price

Market cap $B

0.209

Micro

Exchange

XSHG - Shanghai Stock Exchange

1438908D.SS Stock Analysis

14

Uncovered

HOB Biotech Group Corp Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

65/100

Moderate score

Market cap $B

0.209

Dividend yield

1.73 %

Shares outstanding

63.058 B

HOB Biotech Group Corp. Ltd. engages in the research and development, production, and sale of in-vitro diagnostic reagents. The company is headquartered in Suzhou, Jiangsu and currently employs 431 full-time employees. The company went IPO on 2021-01-13. The firm provides two categories of products: allergy testing products and self-immune testing products. Its detection techniques include qualitative detection techniques such as enzyme-linked immunosorbent assay, and quantitative detection techniques such as enzyme-linked immunoassay capture method and nano-magnetic particle chemiluminescence method. The brands of allergy testing products include Oboke, Fubok, Shibok and Shibok Plus. The self-immune testing product brands include Norbok and Nabok. The company is also engaged in the provision of reagent supporting testing instruments and others. The firm conducts its businesses in the domestic market.

View Section: Eyestock Rating